Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Mechema Chemicals International Corp. (4721.TWO)
Taoyuan, JHR, TW
Mechema Chemicals International Corp. manufactures, imports, exports, and trades sodium acetate, sodium acetate, cobalt compounds, and cobalt compounds, as well as engages in the trading, import, and export of cobalt metal and potassium metal in Taiwan, China, Korea, Thailand, Malaysia, Indonesia, and internationally. The company offers battery cathode and catalyst materials. It provides sulfate, acetate, and bromide solution molecular cobalt related products, as well as nickel molecular and chloride molecular nickel related products. In addition, the company offers CTA waste catalyst recovery and PTA mother liquor systems. Mechema Chemicals International Corp. was founded in 1981 and is based in Taoyuan City, Taiwan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +6.55% | +0.76% | +11.02% | +38.36% | +36.73% | +36.12% | +54.24% | -3.54% | +50.24% | +142.99% | +348.26% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+19.3% ★ Q1'26: +59.1% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-10.2% Q1'26: +122.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+3.7% Q1'26: -13.9% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+12.5% ★ Q1'26: +20.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+15.6% ★ Q1'26: +30.1% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.1% Q1'26: +0.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.78× Q1'26: 1.19× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.35B
est: 2.26B (+3.9%)
|
4.23B
est: 4.18B (+1.0%)
|
4.92B
est: 5.11B (-3.8%)
|
3.31B
est: 3.52B (-5.9%)
|
2.12B
est: 2.26B (-6.2%)
|
2.53B
est: 4.18B (-39.5%)
|
5.11B
5.11B – 5.11B
+22.1% YoY
|
3.52B
3.52B – 3.52B
-31.0% YoY
|
3.52B
3.52B – 3.52B
+0.0% YoY
|
2.12B
2.12B – 2.12B
-39.9% YoY
|
| EBITDA |
242.56M
est: 231.49M (+4.8%)
|
275.46M
est: 427.94M (-35.6%)
|
334.19M
est: 522.71M (-36.1%)
|
308.08M
est: 360.48M (-14.5%)
|
322.75M
est: 259.21M (+24.5%)
|
369.94M
est: 479.19M (-22.8%)
|
585.31M
585.31M – 585.31M
+22.1% YoY
|
403.65M
403.65M – 403.65M
-31.0% YoY
|
403.65M
403.65M – 403.65M
+0.0% YoY
|
242.53M
242.53M – 242.53M
-39.9% YoY
|
| EBIT |
131.05M
est: 211.05M (-37.9%)
|
203.30M
est: 390.16M (-47.9%)
|
216.74M
est: 476.56M (-54.5%)
|
231.73M
est: 328.65M (-29.5%)
|
291.50M
est: 233.62M (+24.8%)
|
315.26M
est: 431.87M (-27.0%)
|
527.51M
527.51M – 527.51M
+22.1% YoY
|
363.79M
363.79M – 363.79M
-31.0% YoY
|
363.79M
363.79M – 363.79M
+0.0% YoY
|
218.58M
218.58M – 218.58M
-39.9% YoY
|
| Net Income |
141.67M
est: 154.56M (-8.3%)
|
207.73M
est: 231.09M (-10.1%)
|
244.14M
est: 268.23M (-9.0%)
|
218.87M
est: 244.60M (-10.5%)
|
251.92M
est: 154.48M (+63.1%)
|
225.72M
est: 230.97M (-2.3%)
|
268.09M
268.09M – 268.09M
+16.1% YoY
|
244.47M
244.47M – 244.47M
-8.8% YoY
|
327.71M
327.71M – 327.71M
+34.0% YoY
|
327.71M
327.71M – 327.71M
+0.0% YoY
|
| SGA |
97.68M
est: 93.96M (+4.0%)
|
97.50M
est: 173.70M (-43.9%)
|
101.92M
est: 212.17M (-52.0%)
|
104.60M
est: 146.32M (-28.5%)
|
137.76M
est: 101.04M (+36.3%)
|
143.13M
est: 186.79M (-23.4%)
|
228.16M
228.16M – 228.16M
+22.1% YoY
|
157.34M
157.34M – 157.34M
-31.0% YoY
|
157.34M
157.34M – 157.34M
+0.0% YoY
|
94.54M
94.54M – 94.54M
-39.9% YoY
|
| EPS |
1.89
est: 2.06 (-8.3%)
|
2.77
est: 3.08 (-10.1%)
|
3.26
est: 3.58 (-8.8%)
|
2.92
est: 3.26 (-10.4%)
|
3.35
est: 2.06 (+62.6%)
|
3.01
est: 3.08 (-2.3%)
|
3.58
3.58 – 3.58
+16.1% YoY
|
3.26
3.26 – 3.26
-8.8% YoY
|
4.37
4.37 – 4.37
+34.0% YoY
|
4.37
4.37 – 4.37
+0.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-28 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-25 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-05 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-04 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.01% | 20.2K | 0.35% |
| 2 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.00% | 2.6K | 0.42% |
| 3 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 13.1K | 0.44% |
| 4 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 125.7K | 0.39% |
| 5 | Avantis Emerging Markets Equity ETF AVEM | 0.00% | 46.8K | 0.33% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Li Kuan Lo | Principal Accounting & Principal Financial Officer | — | — |
| Long Cai Yan | Chairman of the Board and President | — | male |
| Ming Zhe Xie | Vice President and Director | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4721.TWO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
